Health Canada drug identification number

DIN 02548410 — M-BILASTINE 20 MG

M-BILASTINE is a tablet of Bilastine marketed by MANTRA PHARMA INC. The full Bilastine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02548410
Brand name
M-BILASTINE
Active ingredient
Bilastine
Strength
20 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
MANTRA PHARMA INC
Health Canada status
MARKETED
Drug class
Second-generation (non-sedating) H1-antihistamine

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Bilastine products

DINBrandStrengthFormManufacturerStatus
02549883 APO-BILASTINE TABLETS 20 MG TABLET APOTEX INC MARKETED
02541556 AURO-BILASTINE 20 MG TABLET AURO PHARMA INC MARKETED
02519038 BLEXTEN 10 MG TABLET (ORALLY-DISINTEGRATING) ARALEZ PHARMACEUTICALS CANADA INC MARKETED
02519011 BLEXTEN 2.5 MG SOLUTION ARALEZ PHARMACEUTICALS CANADA INC MARKETED
02454130 BLEXTEN 20 MG TABLET ARALEZ PHARMACEUTICALS CANADA INC MARKETED
02544369 GLN-BILASTINE 20 MG TABLET GLENMARK PHARMACEUTICALS CANADA INC. MARKETED
02546795 JAMP BILASTINE 20 MG TABLET JAMP PHARMA CORPORATION MARKETED
02448262 JAMP BILASTINE ORAL SOLUTION 2.5 MG SOLUTION JAMP PHARMA CORPORATION MARKETED
02547279 MAR-BILASTINE 20 MG TABLET MARCAN PHARMACEUTICALS INC MARKETED
02551934 NRA-BILASTINE 20 MG TABLET NORA PHARMA INC MARKETED
02561565 PMS-BILASTINE 20 MG TABLET PHARMASCIENCE INC MARKETED
02536269 SANDOZ BILASTINE 20 MG TABLET SANDOZ CANADA INCORPORATED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.